Connect with us

Awareness

Diseases With Unknown Etiology Trace Back To Mass Vaccination Against Influenza in 1976

Published

on

By James Lyons-Weiler via The World Mercury Project 

Crohn’s. Lupus. Autism. ADHD. Food allergies. Celiac disease. Sjögren’s syndrome. Polymyalgia rheumatica. Multiple sclerosis. Anklyosing spondylitis. Type 1 diabetes. Vasculitis. Peripheral neuropathy. The list goes on, and on, and on. We are being increasingly diagnosed with these conditions and diseases of unknown origin, and science has very little to say – why would autoimmune diseases and mysterious diseases of inflammation be so prevalent? When did this increase start?

advertisement - learn more

As an observer and participant in modern biomedical research, and a lover of deep history, I tend to focus not on the immediate or last few years, but look for trends of accumulating risk over longer periods of time. Seeking an answer to the question of “when”, I used Pubmed to estimate, per yer, the number of studies and papers discussing diseases and conditions of unknown origin. I search for the term “unknown causes”, and also for the term “journal” to get some idea of the percentage of studies, papers and editorials discussing disease of unknown causes. I had no idea what to expect.

Looking at a trend of topics per year, one has to correct for some estimate of the total number of articles published, because a mere count would, in part, reflect the overall trend in the explosion of total articles published. I chose as my control term the word “journal”, because many titles of publications include that term (e.g., “Journal of Nephrology). Here is the control result, which is not surprising, and completely expected:

Again, this merely reflects the trend in the increase in publications in Pubmed, and so using it would provide a relative control for that trend.

Next I searched for “Unknown Causes”, and calculated the number of articles citing unknown causes per 10,000 articles (again, relative denominator term).

advertisement - learn more

What I found is shocking. Here is a graph of the number of articles per 10,000 discussing “unknown causes” (Y = #articles mentioning “unknown causes” / #articles mentioning “journal”, as in the title of journals).

Because the studies in Pubmed include all sorts of journals studying all sorts of things, the actual number is not as important as the trend. The signature is undeniable. Something changed dramatically in 1976. To the skeptic: the increase is greater if one does not correct for total publications.

What changed was national mass vaccination against influenza.

The follow section is excerpted from “Reflections on the 1976 Swine Flu Vaccination Program” by David Sencer and J. Donald Millar. [Link]

Swine Flu at Fort Dix

On February 3, 1976, the New Jersey State Health Department sent the Center for Disease Control (CDC) in Atlanta isolates of virus from recruits at Fort Dix, New Jersey, who had influenza-like illnesses. Most of the isolates were identified as A/Victoria/75 (H3N2), the contemporary epidemic strain. Two of the isolates, however, were not typeable in that laboratory. On February 10, additional isolates were sent and identified in CDC laboratories as A/New Jersey/76 (Hsw1N1), similar to the virus of the 1918 pandemic and better known as “swine flu.”

A meeting of representatives of the military, the National Institute of Health, the Food and Drug Administration (FDA), and the State of New Jersey Department of Health was quickly convened on Saturday, February 14, 1976. Plans of action included heightened surveillance in and around Fort Dix, investigation of the ill recruits to determine if contact with pigs had occurred, and serologic testing of recruits to determine if spread had occurred at Fort Dix.

Surveillance activities at Fort Dix gave no indication that recruits had contact with pigs. Surveillance in the surrounding communities found influenza caused by the current strain of influenza, A/Victoria, but no additional cases of swine flu. Serologic testing at Fort Dix indicated that person-to-person transmission had occurred in >200 recruits (4).

In 1974 and 1975, 2 instances of humans infected with swine influenza viruses had been documented in the United States. Both persons involved had close contact with pigs, and no evidence for spread of the virus beyond family members with pig contact could be found (5).

The National Influenza Immunization Program

On March 10, 1976, the Advisory Committee on Immunization Practices of the United States Public Health Service (ACIP) reviewed the findings. The committee concluded that with a new strain (the H1N1 New Jersey strain) that could be transmitted from person to person, a pandemic was a possibility. Specifically, the following facts were of concern: 1) persons <50 years of age had no antibodies to this new strain; 2) a current interpandemic strain (A/Victoria) of influenza was widely circulating; 3) this early detection of an outbreak caused by A/New Jersey/76/Hsw1N1 (H1N1) provided an opportunity to produce a vaccine since there was sufficient time between the initial isolates and the advent of an expected influenza season to produce vaccine. In the past when a new pandemic strain had been identified, there had not been enough time to manufacture vaccine on any large scale; 4) influenza vaccines had been used for years with demonstrated safety and efficacy when the currently circulating vaccine strain was incorporated; 5) the military vaccine formulation for years had included H1N1, an indication that production was possible, and no documented adverse effects had been described.

ACIP recommended that an immunization program be launched to prevent the effects of a possible pandemic. One ACIP member summarized the consensus by stating “If we believe in prevention, we have no alternative but to offer and urge the immunization of the population.” One ACIP member expressed the view that the vaccine should be stockpiled, not given.

Making this decision carried an unusual urgency. The pharmaceutical industry had just finished manufacture of the vaccine to be used in the 1976–1977 influenza season. At that time, influenza vaccine was produced in fertilized hen’s eggs from special flocks of hens. Roosters used for fertilizing the hens were still available; if they were slaughtered, as was customary, the industry could not resume production for several months.

On March 13, an action memo was presented to the Secretary of the Department of Health Education and Welfare (DHEW). It outlined the problem and presented 4 alternative courses of action. First was “business as usual,” with the marketplace prevailing and the assumption that a pandemic might not occur. The second was a recommendation that the federal government embark on a major program to immunize a highly susceptible population. As a reason to adopt this plan of action, the memo stated that “the Administration can tolerate unnecessary health expenditures better than unnecessary death and illness if a pandemic should occur.” The third proposed course of action was a minimal response, in which the federal government would contract for sufficient vaccine to provide for traditional federal beneficiaries—military personnel, Native Americans, and Medicare-eligible persons. The fourth alternative was a program that would represent an exclusively federal response without involvement of the states.

The proposal recommended by the director of CDC was the second course, namely, for the federal government to contract with private pharmaceutical companies to produce sufficient vaccine to permit the entire population to be immunized against H1N1. The federal government would make grants to state health departments to organize and conduct immunization programs. The federal government would provide vaccine to state health departments and private medical practices. Since influenza caused by A/Victoria was active worldwide, industry was asked to incorporate the swine flu into an A/Victoria product to be used for populations at high risk.

Before the discussions with the secretary of DHEW had been completed, a member of his staff sent a memo to a health policy advisor in the White House, raising the specter of the 1918 pandemic, which had been specifically underemphasized in the CDC presentation. CDC’s presentation highlighted the pandemic potential, comparing it with the 1968–69 Hong Kong and 1957–58 Asian pandemics. President Gerald Ford’s staff recommended that the president convene a large group of well-known and respected scientists (Albert Sabin and Jonas Salk had to be included) and public representatives to hear the government’s proposal and make recommendations to the president about it. After the meeting, the president had a press conference, highlighted by the unique simultaneous appearance of Salk and Sabin. President Ford announced that he accepted the recommendations that CDC had originally made to the secretary of DHEW. The National Influenza Immunization Program (NIIP) was initiated.

The proposal was presented to 4 committees of the Congress, House and Senate authorization committees and House and Senate appropriation committees. All 4 committees reported out favorable legislation, and an appropriation bill was passed and signed.

The estimated budgeted cost of the program was $137 million. When Congress passed the appropriation, newspapers mischaracterized the cost as “$1.9 billion” because the $137 million was included as part of a $1.9 billion supplemental appropriation for the Department of Labor. In the minds of the public, this misconception prevailed.

Immediately after the congressional hearing, a meeting of all directors of state health departments and medical societies was held at CDC. The program was presented by CDC, and attendees were asked for comments. A representative from the New Jersey state health department opposed the plan; the Wisconsin state medical society opposed any federal involvement. Otherwise, state and local health departments approved the plan.

Within CDC, a unit charged with implementing the program, which reported to the director, was established. This unit, NIIP, had complete authority to draw upon any resources at CDC needed. NIIP was responsible for relations with state and local health departments (including administration of the grant program for state operations, technical advice to the procurement staff for vaccine, and warehousing and distribution of the vaccine to state health departments) and established a proactive system of surveillance for possible adverse effects of the influenza vaccines, the NIIP Surveillance Assessment Center (NIIP-SAC). (This innovative surveillance system would prove to be NIIP’s Trojan horse.) In spite of the obstacles discussed below, NIIP administered a program that immunized 45 million in 10 weeks, which resulted in doubling the level of immunization for persons deemed to be at high risk, rapidly identifying adverse effects, and developing and administering an informed consent form for use in a community-based program.

Obstacles to the Vaccination Plan

The principal obstacle was the lack of vaccines. As test batches were prepared, the largest ever field trials of influenza vaccines ensued. The vaccines appeared efficacious and safe (although in the initial trials, children did not respond immunologically to a single dose of vaccine, and a second trial with a revised schedule was needed) (6). Hopes were heightened for a late summer/early fall kickoff of mass immunization operations.

In January 1976, before the New Jersey outbreak, CDC had proposed legislation that would have compensated persons damaged as a result of immunization when it was licensed by FDA and administered in the manner recommended by ACIP. The rationale given was that immunization protects the community as well as the individual (a societal benefit) and that when a person participating in that societal benefit is damaged, society had a responsibility to that person. The proposal was sent back from a staff member in the Surgeon General’s office with a handwritten note, “This is not a problem.”

Soon, however, NIIP received the first of 2 crippling blows to hopes to immunize “every man, woman, and child.” The first was later in 1976, when instead of boxes of bottled vaccine, the vaccine manufacturers delivered an ultimatum—that the federal government indemnify them against claims of adverse reactions as a requirement for release of the vaccines. The government quickly capitulated to industry’s demand for indemnification. While the manufacturers’ ultimatum reflected the trend of increased litigiousness in American society, its unintended, unmistakable subliminal message blared “There’s something wrong with this vaccine.” This public misperception, warranted or not, ensured that every coincidental health event that occurred in the wake of the swine flu shot would be scrutinized and attributed to the vaccine.

On August 2, 1976, deaths apparently due to an influenzalike illness were reported from Pennsylvania in older men who had attended the convention of the American Legion in Philadelphia. A combined team of CDC and state and local health workers immediately investigated. By the next day, epidemiologic evidence indicated that the disease was not influenza (no secondary cases occurred in the households of the patients). By August 4, laboratory evidence conclusively ruled out influenza. However, this series of events was interpreted by the media and others as an attempt by the government to “stimulate” NIIP.

Shortly after the national campaign began, 3 elderly persons died after receiving the vaccine in the same clinic. Although investigations found no evidence that the vaccine and deaths were causally related, press frenzy was so intense it drew a televised rebuke from Walter Cronkite for sensationalizing coincidental happenings.

Guillain-Barré Syndrome

What NIIP did not and could not survive, however, was the second blow, finding cases of Guillain-Barré syndrome (GBS) among persons receiving swine flu immunizations. As of 1976, >50 “antecedent events” had been identified in temporal relationship to GBS, events that were considered as possible factors in its cause. The list included viral infections, injections, and “being struck by lightning.” Whether or not any of the antecedents had a causal relationship to GBS was, and remains, unclear. When cases of GBS were identified among recipients of the swine flu vaccines, they were, of course, well covered by the press. Because GBS cases are always present in the population, the necessary public health questions concerning the cases among vaccine recipients were “Is the number of cases of GBS among vaccine recipients higher than would be expected? And if so, are the increased cases the result of increased surveillance or a true increase?” Leading epidemiologists debated these points, but the consensus, based on the intensified surveillance for GBS (and other conditions) in recipients of the vaccines, was that the number of cases of GBS appeared to be an excess.

Had H1N1 influenza been transmitted at that time, the small apparent risk of GBS from immunization would have been eclipsed by the obvious immediate benefit of vaccine-induced protection against swine flu. However, in December 1976, with >40 million persons immunized and no evidence of H1N1 transmission, federal health officials decided that the possibility of an association of GBS with the vaccine, however small, necessitated stopping immunization, at least until the issue could be explored. A moratorium on the use of the influenza vaccines was announced on December 16; it effectively ended NIIP of 1976. Four days later the New York Times published an op-ed article that began by asserting, “Misunderstandings and misconceptions… have marked Government … during the last eight years,” attributing NIIP and its consequences to “political expediency” and “the self interest of government health bureaucracy” (7). These simple and sinister innuendos had traction, as did 2 epithets used in the article to describe the program, “debacle” in the text and “Swine Flu Fiasco” in the title.

On February 7, the new secretary of DHEW, Joseph A. Califano, announced the resumption of immunization of high-risk populations with monovalent A/Victoria vaccine that had been prepared as part of the federal contracts, and he dismissed the director of CDC.

Lessons Learned

NIIP may offer lessons for today’s policymakers, who are faced with a potential pandemic of avian influenza and struggling with decisions about preventing it (Table). Two of these lessons bear further scrutiny here.

Media and Presidential Attention

While all decisions related to NIIP had been reached in public sessions (publishing of the initial virus findings in CDC’s weekly newsletter, the Morbidity and Mortality Weekly Report (MMWR); New York Times reporter Harold Schmeck’s coverage of the ACIP sessions, the president’s press conference, and 4 congressional hearings), effective communication from scientifically qualified persons was lacking, and the perception prevailed that the program was motivated by politics rather than science. In retrospect (and to some observers at the time), the president’s highly visible convened meeting and subsequent press conference, which included pictures of his being immunized, were mistakes. These instances seemed to underline the suspicion that the program was politically motivated, rather than a public health response to a possible catastrophe.Annex 11 of the draft DHEW pandemic preparedness plan states, “For policy decisions and in communication, making clear what is not known is as important as stating what is known. When assumptions are made, the basis for the assumptions and the uncertainties surrounding them should be communicated” (11). This goal is much better accomplished if the explanations are communicated by those closest to the problem, who can give authoritative scientific information. Scientific information coming from a nonscientific political figure is likely to encourage skepticism, not enthusiasm.

Neither CDC nor the health agencies of the federal government had been in the habit of holding regular press conferences. CDC considered that its appropriate main line of communication was to states and local health departments, believing that they were best placed to communicate with the public. MMWR served both a professional and public audience and accounted for much of CDC’s press coverage. In 1976, no all-news stations existed, only the nightly news. The decision to stop the NIIP on December 16, 1976, was announced by a press release from the office of the assistant secretary for health. The decision to reinstitute the immunization of those at high risk was announced by a press release from the office of the secretary, DHEW. In retrospect, periodic press briefings would have served better than responding to press queries. The public must understand that decisions are based on public health, not politics. To this end, health communication should be by health personnel through a regular schedule of media briefings.

Decision To Begin Immunization

This decision is worthy of serious question and debate. As Walter Dowdle (12) points out in this issue of Emerging Infectious Diseases, the prevailing wisdom was that a pandemic could be expected at any time. Public health officials were concerned that if immunization was delayed until H1N1 was documented to have spread to other groups, the disease would spread faster than any ability to mobilize preventive vaccination efforts. Three cases of swine influenza had recently occurred in persons who had contact with pigs. In 1918, after the initial outbreak of influenza at Fort Riley in April, widespread outbreaks of influenza did not occur until late summer (13).

The Delphi exercise of Schoenbaum in early fall of 1976 (13) was the most serious scientific undertaking to poll scientists to decide whether or not to continue the program. Its main finding was that the cost benefit would be best if immunization were limited to those >25 years of age (and now young children are believed to be a potent source of spread of influenza virus!). Unfortunately, no biblical Joseph was there to rise from prison and interpret the future.

As Dowdle further states (12), risk assessment and risk management are separate functions. But they must come together with policymakers, who must understand both. These discussions should not take place in large groups in the president’s cabinet room but in an environment that can establish an educated understanding of the situation. Once the policy decisions are made, implementation should be left to a single designated agency. Advisory groups should be small but representative. CDC had the lead responsibility for operation of the program. Implementation by committee does not work. Within CDC, a unit was established for program execution, including surveillance, outbreak investigation, vaccine procurement and distribution, assignment of personnel to states, and awarding and monitoring grants to the states. Communications up the chain of command to the policymakers and laterally to other directly involved federal agencies were the responsibility of the CDC director, not the director of NIIP, who was responsible for communications to the states and local health departments, those ultimately implementing operations of the program. This organizational mode functioned well, a tribute to the lack of interagency jealousies.

[End of Excerpt]

This history is fascinating. But the conclusions of those involved in the decision-making about risk is telling: even though they observed Guillain-Barré syndrome in a significant number of individuals, they forged ahead with ACIP telling them it was more important to conduct mass vaccinations.

In 1986, the The National Childhood Vaccine Injury Act (NCVIA) established the National Vaccine Injury Compensation Program. Guillain-Barré Syndrome was added to the table of vaccine injuries for which compensation is awarded in 2017. It took thirty-one years to add GBS to the table, and they knew about the assocation for ten years before the 1986 act.

When assessing risk, there are the knowns, the unknowns, and the unknowns one does even know to look for. The “Reflections” article, on the CDC website, shows that knowledge of risk of autoimmune disorders like Guillain-Barré Syndrome and deaths from vaccination was present from the beginning.

Serious side effects in a minority of patients is rationalized by the benefits of the flu vaccine, and vaccine risk denialism perpetuates the regulation of perception necessary for continuation of the view that the benefits outweigh the risks.

But, at a population level, evidence is mounting that, due to numerous reasons, mass influenza vaccination is self-defeating.

The facts in the scientific literature that must be considered include:

(1) A/H3N2 disease vaccinated individuals were significantly more likely to report myalgias (OR 3.31; 95% CI [1.22, 8.97]) than vaccinated individuals. [Vaccine-associated reduction in symptom severity among patients with influenza]

(2) Vaccination with Thimerosal induces immunological damage. Specifically, Thimerosal inhibits the protein ERAP1, which shortens proteins headed for the cell surface of MHC Class 1 [“Stamogiannos et al., 2016 Screening Identifies Thimerosal as a Selective Inhibitor of Endoplasmic Reticulum Aminopeptidase 1″]

(3) Vaccination against Influenza with thimerosal-containing vaccines is associated with an increase in non-influenza respiratory infections [“Increased Risk of Noninfluenza Respiratory Virus Infections Associated With Receipt of Inactivated Influenza Vaccine“]

(4) Repeated vaccination at a young age substantially increases the risk of influenza in older age, by a factor ranging between 1. 2 (vaccination after 50 years) to 2. 4 (vaccination from birth) [“Repeated influenza vaccination of healthy children and adults: borrow now, pay later?“]

(5) B-cells activated by flu vaccine crowds out B-cells for other viruses [“Why Flu Vaccines So Often Fail, Science Magazine“]

(13) The evidence that heterologous immunity and very limited efficacy makes universal vaccination against the flu will create more disease than it prevents is impressive. [Why do people get the flu after getting the flu shot?]

(8) The rate of aerosol shedding among cases with vaccination in the current and previous season is higher than that in people with no vaccination in those two seasons. [“Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community“]

(10) Repeated flu shots may blunt effectiveness [“Repeated flu shots may blunt effectiveness“]

These observations also exist at the population level. CDC annually reports both the influenza vaccine uptake and estimates of the adjusted vaccine efficacy (AVE). If the AVE of two years following the efficacy of a given year is regressed, the annual loss in efficacy in the flu vaccine due to the flu vaccine is 1.167 units of AVE per percentage increase in flu vaccine uptake:

These result are from CDC’s own data, and reflect population effects. They are robust to the low coverage value ‘outlier’, data provided here for the interested skeptic. seasonal-flu-vaccine-effectiveness .

Repeated calls for addressing these conundrums fall on deaf ears. The explosion of diseases of mysterious origin – the cost of morbidity and mortality – means there is no excuse for sloppy, lazy vaccinology. The changes needed are known, and there is no excuse. Unsafe epitopes that match human proteins must be removed. Thimerosal must be removed. Aluminum exposure must be minimized.

We desperately need a new generation of technologies for artificial immunization, and those products should (a) not be contracted via the CDC at all, (b) subjected to the same rigorous standards of evidence of safety required of drugs with long-term safety outcomes (total health outcome awareness), (c) vaccine risk denialism must be stopped immediately.

The 1976 risk policy assumptions are summarized by Sencer and Millar:

Decision-making” Risks

When lives are at stake, it is better to err on the side of overreaction than underreaction. Because of the unpredictability of influenza, responsible public health leaders must be willing to take risks on behalf of the public. This requires personal courage and a reasonable level of understanding by the politicians to whom these public health leaders are accountable. All policy decisions entail risks and benefits: risks or benefits to the decision maker; risks or benefits to those affected by the decision. In 1976, the federal government wisely opted to put protection of the public first.” (emphasis added)

At this point, in 2018, one must ask: when will protection from vaccine-induced immunological and neurological damage become a factor in the risk equations, or better yet, a priority? When will it be seen as more important than the management of the perception of risk?

Additional Considerations

A minority of ‘flu’ cases involve influenza [“Influenza: marketing vaccines by marketing disease“] Very few “flu deaths” involve influenza virus infection [“Are US flu death figures more PR than science?”]

Many of the deaths attributed to infuenza may be due to “sudden deterioration” observed due to Tamiflu treatment. [“Oseltamivir and early deterioration leading to death: a proportional mortality study for 2009A/H1N1 influenza“]

The arguments for uniform healthcare worker influenza vaccination are not supported by existing literature. [What, in Fact, Is the Evidence That Vaccinating Healthcare Workers against Seasonal Influenza Protects Their Patients? A Critical Review]

The number needed to treat to prevent one infection is 71, and vaccination has no net positive effect on working days or hospitalization. [“Vaccines to prevent influenza in healthy adults“].

ACIP selectively picks results of science to support influenza vaccine and ignores results that question efficacy and safety. [Guidelines in disrepute: a case study of influenza vaccination of healthcare workers ]

Children Who Get Flu Vaccine Have Three Times Risk Of Hospitalization For Flu, Study Suggests [LINK1] [LINK2]

Antivirals if used early can reduce pneumonia and bronchitis, but appear to come with a risk of psychiatric episodes. [Narayana Manjunatha, N et al. 2011.  The neuropsychiatric aspects of influenza/swine flu: A selective review Ind Psychiatry J. 20(2): 83–90.]

 Studies are needed to determine if “flu infection” after influenza vaccination followed by Tamiflu treatment is a recipe for mortality. [Pediatric advisory committee briefing for Tamiflu – Hoffman-La Roche, Inc. ] FDA Posts Tamiflu Warning.

Sign up for free news and updates from Robert F. Kennedy, Jr. and the World Mercury Project. Your donation will help to support us in our efforts.

Start Your Free 7 Day Trial To CETV!

Due to the pressure of mass censorship, we now have our own censorship-free, and ad-free on demand streaming network!

It is the world's first and only conscious media network streaming mind-expanding interviews, news broadcasts, and conscious shows.

Click here to start a FREE 7-Day Trial and watch 100's of hours of conscious media videos, that you won't see anywhere else.

Advertisement
advertisement - learn more

Awareness

Johnson & Johnson Found To Have Knowingly Allowed Asbestos In Their Baby Powder

Published

on

In Brief

  • The Facts:

    Johnson and Johnson have recently lost lawsuits for negligence in knowingly allowing carcinogenic substances in their talc-based hygiene products.

  • Reflect On:

    Are we starting to turn the page on an era where human health and safety are not the prime considerations in the manufacturing of consumer products?

We are starting to awaken to the fact that it seems to be the rule, and not the exception, that large Western corporations put profits above human health considerations. The only time they seem to give any regard to human health concerns is when their forecasts of potential lawsuits down the road would likely exceed the cost measures needed to ensure the safety of their product.

Johnson & Johnson is just one of a long line of corporate perpetrators who believed that covering up and lying about known health concerns would make better business sense than taking the time and resources to actually address those health concerns within their products.

Contaminated Baby Powder: The Height Of Indignity

One would think, regardless of an understanding that the bottom line is a priority for most private companies, that the health and safety of a nursing mother and her newborn child would be sacrosanct for any industry. The reality is that this is simply not the case, even though J&J could have mitigated this problem from the start.

Companies that mine talc are required to take extra steps to ensure the absence of asbestos in their talc. Instead, J&J allegedly went to great lengths to fake it.

Not only did the company know about the asbestos contamination, evidence suggests, but J&J also failed to warn its customers about the link between Baby Powder and cancer or replace its talc with a safer alternative. As a result, J&J guaranteed its customers’ exposure to asbestos.

And regardless of their size or numbers, asbestos fibers are lethal at any capacity. As the World Health Organization (WHO) has stressed repeatedly, there is no safe level of exposure. (source)

advertisement - learn more

The Testimony of Scientist James Webber

Baby Powder’s contamination with asbestos (a mineral that naturally occurs near talc) has long been the subject of lawsuits. But only in recent years has evidence begun to unravel J&J’s defense – that the company had no idea – and threatened its success in lawsuits to come.

In March, a California jury awarded $29 million to Terry Leavitt, a woman who said that asbestos in Johnson & Johnson’s talcum-powder-based products caused her terminal mesothelioma. Environmental scientist James Webber testified in her high-profile California trial and made these observations:

During several hours on the stand, Webber explained how he ran tests that showed “clear” evidence of asbestos contamination in the mines from which J&J sourced talc.

“The testing I have seen [shows] that it was present at least as early as 1971 and up through the late 1990s,” said Webber, who ran an asbestos laboratory in New York state.

Despite denying it publicly, J&J had observed this contamination in internal memos. Its notes dismissed the amount of asbestos in its talc as “but a trace,” Webber alleged. But that was just an optimistic interpretation of superficial testing, he said: the tests used methods too weak to detect microscopic asbestos fibers. Webber insisted the actual tests results revealed there could be millions of asbestos fibers per gram of talc.

And J&J’s inaccurate reports were allegedly only the tip of the iceberg. In some instances, Webber said, photos attached to J&J’s reports revealed that “they had been seeing it and not reporting it.”  (source)

And It’s Getting Worse

The $29 million verdict, in California Superior Court in Oakland, was the latest defeat for the healthcare conglomerate facing more than 13,000 talc-related lawsuits nationwide. And things may be getting even worse for J&J, according to ZeroHedge:

Johnson & Johnson shares are down over 5% after Bloomberg reports that, according to people with knowledge of the matter, the U.S. Justice Department is pursuing a criminal investigation into whether Johnson & Johnson lied to the public about the possible cancer risks of its talcum powder…

Now, a grand jury in Washington is examining documents related to what company officials knew about any carcinogens in their products, the people said.

The Takeaway

It seems as though corporations have long been willing to take the calculated risk of short-cuts and denials instead of ensuring that their products are safe for public use. My suspicion is that a part of our collective awakening process will be issuing in a new business paradigm in which human health and safety become paramount.

Start Your Free 7 Day Trial To CETV!

Due to the pressure of mass censorship, we now have our own censorship-free, and ad-free on demand streaming network!

It is the world's first and only conscious media network streaming mind-expanding interviews, news broadcasts, and conscious shows.

Click here to start a FREE 7-Day Trial and watch 100's of hours of conscious media videos, that you won't see anywhere else.

Continue Reading

Awareness

Prescription Infant Formulas Found To Be Contaminated With Aluminum

Published

on

In Brief

  • The Facts:

    Multiple brands of prescription infant formula were found to contain high levels of aluminum.

  • Reflect On:

    Should we be questioning the quality of products that come from pharmaceutical production? Do we veer away from natural methods of raising children more than we should? At what cost?

You may not think aluminum is a big deal, but it is. For anybody who has looked into aluminum toxicology, it’s quite clear and apparent that it has no place inside of any living biological organism. Putting it simply, it wreaks havoc on our biology. High amounts of aluminum have been found in the brains of people with Alzheimer’s disease, with experts in the field believing that aluminum brain accumulation may be one of the main causes of Alzheimer’s disease.

It’s also been discovered within the brains of MS patients, and some of the highest aluminum content ever recorded in brain tissue has also been discovered in people with autism. Aluminum is associated with several diseases. But an adult body can do a great job of flushing out aluminum.

Despite the fact that aluminum has no place within earth’s biota, it’s still present in many of our medications, our food, and even in the water that we drink due to contamination since the industrial revolution. Aluminum inside the body is a new phenomenon and still understudied. Again, there is a threshold, and aluminum that is injected via vaccines doesn’t exit the body–there is strong evidence that it remains inside the body and ends up in distant organs and eventually inside of the brain. If you want to access more studies on that topic, you can read this article I published that provides them and goes into more detail. You can also watch this interview with Christopher Exley, where he also points to that fact.

A new study published in the International Journal of Environmental Research and Public Health has shown that multiple popular infant prescriptions are contaminated with aluminum. You may be asking how much aluminum, but the authors make it a point to stress that there are no safe amounts of aluminum levels that can be inside of a human body, let alone a newborn baby. That being said, the amounts found are listed within the abstract of the study:

Historical and recent data demonstrate that off-the-shelf infant formulas are heavily contaminated with aluminium. The origin of this contamination remains to be elucidated though may be imported via ingredients, packaging and processing. Specialised infant formulas exist to address health issues, such as low birth weight, allergy or intolerance and medical conditions, such as renal insufficiency. The aluminium content of these prescription infant formulas is measured here for the first time. We obtained 24 prescription infant formulas through a paediatric clinic and measured their total aluminium content by transversely heated graphite furnace atomic absorption spectrometry following microwave assisted acid/peroxide digestion. The aluminium content of ready-to-drink formulas ranged from 49.9 (33.7) to 1956.3 (111.0) μg/L. The most heavily contaminated products were those designed as nutritional supplements for infants struggling to gain weight. The aluminium content of powdered formulas ranged from 0.27 (0.04) to 3.27 (0.19) μg/g. The most heavily contaminated products tended to be those addressing allergies and intolerance. Prescription infant formulas are contaminated with aluminium.

Another very important point made right off the bat by the authors:

advertisement - learn more

Human exposure to aluminium is a serious health concern. Aluminium exposure in infants is understandably a burgeoning issue. While infant exposure to aluminium continues to be documented, its consequences, immediate and in the future, have received only scant attention and research is required to understand the biological availability of aluminium through formula feeding. For example, how much aluminium is absorbed across the neonate gut and its subsequent fate, including excretion.

There is already too much aluminium in infant formulas and herein we have measured its content in a large number of prescription formulas, products which are fed to vulnerable infants in their first months of life. Many of these products are heavily contaminated with aluminium.

As for the specific infant formulas, you can refer to the study. The researchers obtained 24 prescription infant formulas via the Paediatric Clinic of Russells Hall Hospital in Dudley, United Kingdom. The ready-to-drink and powdered products were new, ready-to-be used and unopened samples. These formulas are for babies with some sort of growth restriction, like for preterm infants or infants who have poor weight gain. There were also powdered formulas for allergies and intolerances and powdered formulas with additional amino acids.

The authors contacted each manufacturer and expressed that they denied knowing that there was any aluminum in their products, which means it’s still a mystery as to their source. The authors hypothesize on a number of ways that aluminum could be entering into the formulas.

In their conclusion, the authors emphasize that:

Where possible, breast milk feeding should be prioritised, as the aluminium content of breast milk is invariably an order of magnitude lower than in formula feeds. Where infant formulas are the only source of nutrition for many infants in their first weeks and months of life, aluminium ingested in formula feeds will be the major contributor to their body burden of aluminium. The last thing that vulnerable infants fed specialised formulas for their specific nutritional/medicinal need is additional aluminium in their diet.

Detoxing

There is a lot of information out there on how a person can detox from aluminum and other heavy metals. There are multiple studies, and based on what I’ve looked into, water with high amounts of Silica are effective in draining aluminum out of your body and brain. Herbs like cilantro and substances like chlorella and spirulina are also great for removing some metals. The information is out there, so be sure to do your research.

The Takeaway

It’s concerning to think about what these corporations are doing. Again, aluminum should hold no place in our society, it should’ve remained well below our surface as part of the Earth’s crust for a reason. It wasn’t until humans began digging it out and using it for a number of things, irresponsibly I might add, that we started to see the health implications which still go largely ignored by the medical community.

In fact, heavy metal accumulation and detoxification of aluminum haven’t been addressed at all, which is odd given the fact that heavy metal accumulation is linked to a variety of diseases.

Start Your Free 7 Day Trial To CETV!

Due to the pressure of mass censorship, we now have our own censorship-free, and ad-free on demand streaming network!

It is the world's first and only conscious media network streaming mind-expanding interviews, news broadcasts, and conscious shows.

Click here to start a FREE 7-Day Trial and watch 100's of hours of conscious media videos, that you won't see anywhere else.

Continue Reading

Awareness

9 Studies You Should Be Aware of Before Trying The Ketogenic Diet

Published

on

In Brief

  • The Facts:

    The Ketogenic diet is a popular fad diet that promotes quick weight loss and symptom management for bodies that are dealing with poor lymph, kidney and digestion health.

  • Reflect On:

    Based on the studies that are emerging, is our desire for quick weight loss more important than living a long and healthy life? Are we learning about these diets primarily through those with strong ties to upholding these diets?

The ketogenic diet has popped up as a popular approach to weight loss in the last few years. Is it successful at that? Sure, it is. I’ve experimented with the diet myself years ago when I was looking to lose some belly fat. I was entering into ketosis in a different way than most, as I was not eating any animal products, but it does in fact work.

But like any animal product based diet, what are the consequences of eating so much food that does not truly jive with our human bodies? Not only that, is fast weight loss more important than keeping our morality rate down?

In the last few years, we’ve reported a lot on the Keto diet and the various ways it can be done. We have explored the studies, the results and in some ways, we supported it. But lately, I have been thinking about how supporting this could actually be encouraging people to jump into these diets, including the paleo diet, when in reality these diets increase mortality rates and are not healthy for the human body.

It became a thought in the back of my mind, I have always strived to put the best information out that I can through this platform to promote good health. And so we must look at that, even if that means upsetting some people who currently are on paleo or keto and are seeing some good weight loss or symptom management. The truth is, like the many people I’ve seen crash on these diets after a few years, I want people to know the truth of what’s going on out there. And how we can get beyond diets that symptom manage, and instead get onto diets that truly heal.

Anytime we have fad diets, which paleo and keto are, we see products and bias pop up all over the place to support the continuation of these trends. It becomes less about health and more about upholding an identity or a business.

So as I recently looked into what experts are saying about these diets, I came upon two important videos I think everyone should check out. Both have been embedded below. Remember, it’s not that I care what you choose in your own life, or that I feel there is a right or wrong, it’s that I believe we should be informed and I wish to use this platform to promote as best a message as I can.

advertisement - learn more

The Videos

Thanks to Plant-Based News for creating such a good channel and resource of information on YouTube.

In this video, several plant-based health experts talk through 9 nutrition studies that would be of interest to low carb keto diet proponents. To read the 9 studies, click here.

Next up, Dr. Kim Williams (past President of the American College of Cardiology) shares his insights about the ketogenic.

Related Articles

Diabetic Shares Why He Quit ‘The Ketogenic Diet’

Doctor Explains Why She Never Recommends The ‘Ketogenic Diet’

The Biggest Misconception About The ‘Ketogenic Diet’…You Don’t Actually Have To Follow It

Start Your Free 7 Day Trial To CETV!

Due to the pressure of mass censorship, we now have our own censorship-free, and ad-free on demand streaming network!

It is the world's first and only conscious media network streaming mind-expanding interviews, news broadcasts, and conscious shows.

Click here to start a FREE 7-Day Trial and watch 100's of hours of conscious media videos, that you won't see anywhere else.

Continue Reading
advertisement - learn more
advertisement - learn more

Video

Pod

Stream mind-expanding videos

DISCLOSURE | CONSCIOUSNESS | HEALTH | BREAKING NEWS

You have Successfully Subscribed!